Abstract
Abstract5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a potent classical psychedelic known to induce changes in locomotion, behaviour, and sleep in rodents. However, there is limited knowledge regarding its acute neurophysiological effects. Local field potentials (LFPs) are commonly used as a proxy for neural activity, but previous studies investigating psychedelics have been hindered by confounding effects of behavioural changes and anaesthesia, which alter these signals. To address this gap, we investigated acute LFP changes in the hippocampus (HP) and medial prefrontal cortex (mPFC) of freely behaving rats, following 5-MeO-DMT administration. 5-MeO-DMT led to an increase of delta power and a decrease of theta power in the HP LFPs, which could not be accounted for by changes in locomotion. Furthermore, we observed a dose-dependent reduction in slow (20–50 Hz) and mid (50–100 Hz) gamma power, as well as in theta phase modulation, even after controlling for the effects of speed and theta power. State map analysis of the spectral profile of waking behaviour induced by 5-MeO-DMT revealed similarities to electrophysiological states observed during slow-wave sleep (SWS) and rapid-eye-movement (REM) sleep. Our findings suggest that the psychoactive effects of classical psychedelics are associated with the integration of waking behaviours with sleep-like spectral patterns in LFPs.
Publisher
Springer Science and Business Media LLC
Reference79 articles.
1. Barsuglia, J. P. et al. Chapter 5—A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder. In Progress in brain research Vol. 242 (ed. Calvey, T.) 121–158 (Elsevier, 2018).
2. Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M. & Renn, E. The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption. J. Psychopharmacol. (Oxford, England) 32, 779–792 (2018).
3. Ingvar, D. H. & Soderberg, U. The effect of LSD-25 upon the cerebral blood flow and EEG in cats. Experientia 12, 427–429 (1956).
4. Ornelas, I. M. et al. Nootropic effects of LSD: Behavioral, molecular and computational evidence. Exp Neurol 356, 114148 (2022).
5. Ott, J. Pharmepéna-Psychonautics: Human intranasal, sublingual and oral pharmacology of 5-methoxy-N N-dimethyl-tryptamine. J. Psychoact. Drugs 33, 403–407 (2001).